Meeting Banner
Abstract #1508

Metabolomic Characterization of Human Prostate Cancer with Intact Tissue MRS

Rosa Rossling1, Johannes Kurth1, Emily Decelle2, Chin-Lee Wu2, W Scott McDougal2, Leo L. Cheng2

1Charit Universittsmedizin, Berlin, Germany; 2Massachusetts General Hospital, Boston, MA, United States

A 2005 publication on the investigations of human prostate cancer metabolomics led to two major conclusions that metabolomic profiles can differentiate tissue specimens with and without cancer glands, as well as patient pathological stages. However, this study only proposed the metabolomic structure from the analysis of a training cohort and did not evaluate another independent testing cohort. In this study we followed the concepts of previous report and analyzed tissue samples from prostate cancer patients with constructions of training and testing cohorts.

Keywords

according acknowledge added alanine among analyzed authors benign biomedical biopsy calibrated cancer canonical central characterization characterized chin choline cohort cohorts corrections designed detailed diagnostic differentiate differentiating either evaluated evaluation experimental external field formed frequency furthermore general glands grants hospital house human hypothesis hypothesized improved included independent individual inserts intact integrated intensities internal lactate listed locking magic measured metabolic metabolite metabolites normalized operating partial pathological patient patients percentage peripheral placed plastic potentials profile profiles prognostic program prostate protocols proven recorded repetition report represented resolution rotor samples score specimens spectra spectrometer spectroscopy spinning stage stages statistically subjected support synchronized table tissue training transients transitional volume water zone zones